• People

    Advanced Search

  • Services
  • All Services

  • Back to News & Media
    Blog

    What to Know About the Latest Updates in Ozempic and Wegovy Lawsuits

     Download as PDF

    Key takeaways:

    • Lawsuits claim that Novo Nordisk, the manufacturer, did not sufficiently warn doctors and patients about the risk of severe gastrointestinal conditions like gastroparesis, or “stomach paralysis.”
    • To manage the large number of cases, federal lawsuits have been consolidated into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, a key venue for residents of Pennsylvania and New Jersey.
    • The primary injury cited in these claims is severe gastroparesis, a condition where the stomach cannot empty itself properly, leading to chronic vomiting, pain, and malnutrition.

    The legal claims against Novo Nordisk are not about banning the drug. They are about accountability and informed consent. The core of these lawsuits is the product liability principle known as “failure to warn.”

    SCHEDULE A FREE CONSULTATION

    A Manufacturer’s Duty to Consumers

    logoPharmaceutical companies have a legal duty to inform the medical community and the public about the known risks of their products. This information allows doctors and patients to make educated decisions about their healthcare. 

    Plaintiffs in the Ozempic and Wegovy lawsuits argue that the manufacturer knew, or should have known, about the potential for severe stomach paralysis but did not reflect this danger on the warning label.

    Distinguishing side effects from severe injury

    Many medications have mild, temporary side effects. The warning labels for these drugs did mention nausea and vomiting. 

    However, the lawsuits contend that the manufacturer’s warnings did not prepare anyone for the severity, permanence, and debilitating nature of conditions like gastroparesis, a condition that is a complete and often irreversible shutdown of stomach function.

    Centralization of lawsuits 

    As individuals nationwide filed lawsuits with similar allegations, the federal court system recognized the need for a more efficient process. This led to the creation of multidistrict litigation, or MDL.

    In February 2024, a judicial panel issued a transfer order to consolidate all federal Ozempic and Wegovy lawsuits into a single proceeding. This MDL, assigned to the Eastern District of Pennsylvania in Philadelphia, streamlines pretrial activities. 

    An MDL is not a class-action lawsuit; each plaintiff’s case remains individual.

    Managing these complex cases requires a structured approach. The MDL process helps coordinate evidence gathering and legal rulings, which is beneficial for plaintiffs with similar claims.

    Why the eastern district of Pennsylvania matters

    The selection of Philadelphia as the venue for this MDL is significant for people in the region. With Stark & Stark’s offices in both Pennsylvania and New Jersey, our personal injury attorneys are positioned to represent local clients in this national litigation. It allows for direct participation in a legal process happening right in our community.

    Gastroparesis: The Heart of the Claims

    The primary injury alleged in these lawsuits is gastroparesis, a medical term for stomach paralysis. This condition is devastating and can require lifelong medical management. It occurs when the stomach muscles no longer function to move food into the small intestine.

    Stomach paralysis

    Doctor holding a stethoscope with justice scales in the background, symbolizing medical malpractice law.For those affected, gastroparesis means living with constant nausea, frequent and violent vomiting of undigested food, severe abdominal pain, and significant weight loss. 

    Patients may require feeding tubes to get necessary nutrition. The condition profoundly impacts a person’s ability to work, socialize, and lead a normal life.

    If you believe you have been harmed by one of these medications, taking organized steps can help protect your health and your legal rights. 

    Your immediate focus should be on your medical care and documenting your experience.

    • Continue to follow the advice of your treating physicians.
    • Keep a detailed journal of your symptoms, medical appointments, and daily challenges.
    • Gather all prescription records showing your history of using the medication.
    • Preserve any communications you have had with your doctor about your side effects

    This information provides the factual foundation an attorney needs to evaluate your potential claim and advise you on the next steps.

    Connecting the drug’s action to the injury

    Ozempic and Wegovy belong to a class of drugs called GLP-1 receptor agonists. They work in part by slowing down digestion, which helps control blood sugar and makes a person feel full longer. The lawsuits allege that this slowing effect goes too far in some people, leading to a near-complete shutdown of stomach motility.

    What to Expect as the Litigation Moves Forward

    Now that the MDL is established, the litigation enters a critical phase of evidence gathering and legal arguments. The process will take time, but it is a necessary step toward uncovering the facts.

    The court will establish a schedule for attorneys to exchange documents and take testimony from company employees, medical experts, and the plaintiffs themselves. 

    FAQ for Ozempic and Wegovy Lawsuits

    What specific drugs are included in these lawsuits?

    The current MDL primarily includes lawsuits related to Ozempic, Wegovy, and Rybelsus, all of which are manufactured by Novo Nordisk. Other similar drugs, like Mounjaro, may be subjects of separate or future litigation.

    What if I was taking the drug for type 2 diabetes versus weight loss?

    The reason for your prescription does not affect your eligibility to file a claim. The core issue is whether you took the drug and subsequently developed a severe, improperly warned-of condition like gastroparesis, regardless of the initial diagnosis.

    How do I prove the medication caused my stomach condition?

    Your attorney will work with medical experts to establish a causal link. This involves a thorough review of your medical records to show a clear timeline between starting the medication and the onset of severe gastrointestinal symptoms, while also working to rule out other potential causes.

    Is it too late to file a lawsuit?

    Each state has a statute of limitations, which is a deadline for filing a product liability claim. Because the knowledge of this potential link is relatively new, it is crucial to speak with an attorney as soon as possible to protect your right to file.

    Let Us Review Your Case

    If you or a loved one took Ozempic or Wegovy and suffered from stomach paralysis or other severe intestinal problems, you deserve answers. 

    Stark & Stark’s mass tort attorneys are actively investigating these claims and can help you understand your legal options. Contact us at 800.535.3425 or fill out our online form for a free and confidential case evaluation.

    SCHEDULE A FREE CONSULTATION

    Firm Highlights

    Stark & Stark Shareholder Deborah S. Dunn, Esq. Installed as 2nd Vice President and Diversity Officer of the New Jersey Association for Justice for 2026–2027

    Stark & Stark is proud to announce that Shareholder Deborah S. Dunn, Esq. has been installed as 2nd Vice President and Diversity Officer of the...

    Stark & Stark Recognized with Community Partner Award by Mercer County Community College Foundation

    Stark & Stark is proud to announce that the firm has been recognized with the Community Partner Award by the Mercer County Community College...

    Carin A. O’Donnell, Esq. Inducted as 2026-2027 President of the Pennsylvania Association for Justice

    Stark & Stark is proud to announce that Carin A. O'Donnell, Esq. was sworn in as the 2026-2027 President of the Pennsylvania Association for...

    Stark & Stark’s Thomas S. Onder, Esq. Receives 2026 ICSC Trustees’ Distinguished Service Award

    Stark & Stark is proud to announce that Thomas S. Onder, Esq., Shareholder and Chair of the Firm’s Shopping Center & Retail Development...

    Stark & Stark’s Joseph H. Lemkin Esq., Named 2026 Professional Lawyer of the Year for the Jewish Bar Association of New Jersey

    Stark & Stark is proud to announce that Joseph H. Lemkin Esq. has been selected by the New Jersey Commission on Professionalism in the Law as...

    Our Values Remain: A Message on the Closing of Diversity Lab

    Stark & Stark is saddened and disappointed to learn that Diversity Lab, the organization that created and manages the Mansfield Certification...

    Congratulations to Shareholder Bhaveen R. Jani, Esq. on his Installation as Treasurer of the Middlesex County Bar Foundation

    Stark & Stark is proud to announce that Shareholder Bhaveen R. Jani, Esq. has been installed as Treasurer of the Middlesex County Bar Foundation,...

    Denise Mariani, Esq., and Jonathan Lauri, Esq. Secure $750,000 Jury Verdict Against Hamilton Healthcare and Rehabilitation Center

    It is our pleasure to announce that Denise Mariani, Esq., and Jonathan Lauri, Esq., secured a $750,000 jury verdict on behalf of a nursing home...

    Stark & Stark Welcomes 2026 Summer Law Clerks

    Stark & Stark is proud to announce its 10th Annual Summer Law Clerk Program. Five Summer Law Clerks will join the firm from June through July...

    Retail Development Team Secures Major Recovery for Landlord Client Amid Bankruptcy Dispute

    Our Shopping Center and Retail Development Group recently secured a multi-million-dollar settlement for a commercial landlord client' s property...

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. Secure $950,000 Settlement in Surgical Malpractice Matter

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. recently secured a confidential $950,000 settlement in a surgical malpractice case. “This...

    Victoria Wilton, Esq. Selected to Serve on New Jersey State Bar Association Family Law Executive Committee

    We are proud to announce that Victoria Wilton, Esq. has been selected to serve on the New Jersey State Bar Association Family Law Executive Committee...